Partner With Us NRI

Company details

6M Return 1.37%
1Y Return -15.52%
Mkt Cap.(Cr) 7,699.35
Volume 129,859
Div Yield 0.48%
OI Chg %
Volume 129,859

Open Free Demat Account Online with ICICIDIRECT


  • swot

  • technicals

  • deals

  • shareholding


Delivery and volume

Our Research View

Trading recommendation

Data not found

Investment recommendation

Call Date

20 May 2022

Entry Price


Target Price



12-18 Month

Rapid Results

Q4FY22 Quarterly Result Announced for Granules India Ltd.

Pharmaceuticals firm Granules India declares Q4FY22 result:

  • Granules India reports Income from operations at INR 1,030 Cr up 29% YoY, EBITDA at INR 193 Cr, EBITDA Margin at 19%; PAT at INR 111 Cr.
  • The Board of Directors have recommended final dividend of 75 paise per equity share of Re.1/- each in addition to interim dividend of 75 paise per equity share of Re.1/- each paid during the year.
  • Revenue for Q4FY22 stood at INR 1,030Crs, growth of 29% YoY across all geographies and segments. Revenue share from Europe increased to 21.5% when compared to 14.5% YoY.
  • Increase in Revenue, EBITDA and PAT in Q4FY22 compared to Q3FY22, despite adverse business condition arising out of supply constraints of Para Amino Phenol (PAP), other input price cost increase and logistic cost increase.
  • Revenue share of non-core molecules stood at 19% on a full year basis versus 16% in the previous year, in line with our long-term strategy
  • During the quarter we filed one ANDA, two US DMF, and received two ANDA approvals.

Commenting on the results, Dr Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “FY 22 has been a challenging year for the industry in the face of adverse external environment with headwinds around the availability and price for Raw Materials, Solvents, Catalysts, uncertainties arising out of Ukraine-Russia conflict as well as reemergence of Covid cases in China. The global supply chain and logistics continue to remain under duress. In face of these challenges, Granules has demonstrated great resilience and I am happy with the performance of the Company. While we strive for continued improvement in our financial performance in the short term, we are working on long term strategy for making ourselves self-sustainable and overcome most of the challenges that we are facing now. We are now embarking on a new journey to reimagine our business model and transform Granules to an Innovative, science & technology driven organization, with responsible sustainable operations.”


Result PDF


  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio


Operating Profit(Cr.)

Profit after Tax(Cr.)


Reserves and Surplus



Operating Profit

Profit after tax





Equity Capital: 2,586.53 Cr FV: 1.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 1,063.73 35,237.03
LAST 3M 39,397.70 -2,125.67
LAST 6M 127,269.18 -146,884.65
LAST 12M 212,893.82 -215,286.28


  • About Company
  • Company Info
  • Listing Info

Registered Address

Second Floor Block III, My Home Hub Madhapur, Hyderabad, Telangana, 500081

Tel : 91-40-66760000
Email : investorrelations:granulesindia.com
Website : http://www.granulesindia.com


CIL Securities Limited

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 532482
Book Closure Date (Month) : Jul/Aug
BSE Group : A
ISIN : INE101D01020

ICICIdirect Granules India Ltd FAQ

You can buy Granules India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Granules India Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 12, 2022 04:01 PM the closing price of Granules India Ltd was ₹ 310.45.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 12, 2022 04:01 PM, the market cap of Granules India Ltd stood at ₹ 7,699.35.
The latest PE ratio of Granules India Ltd as of Aug 12, 2022 04:01 PM is 18.35
The latest PB ratio of Granules India Ltd as of Aug 12, 2022 04:01 PM is 0.34
The 52-week high of Granules India Ltd is ₹ 374.70 while the 52-week low is ₹ 227.00 .
According to analyst recommendations, Granules India Ltd has a “Buy” rating for the long term.

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote